BRIGhTMIND study: long-term efficacy of rTMS for treatment-resistant depression
BRIGhTMIND is a study which highlights the long-term efficacy of repetitive transcranial magnetic stimulation (rTMS) for patients with treatment-resistant depression. When compared with connectivity-guided intermittent theta burst stimulation (cgiTBS) in a randomized control trial, both treatments were equally effective, with persistent decreases in depressive symptoms seen over 26 weeks.
Click here to read the full article